Ingenskin Therapeutics

Developing personalised skin grafts from patients' own cells

Severe burns destroy the skin's protective barrier, exposing patients to infection and fluid loss. Reconstructive treatment can be constrained by a shortage of healthy donor skin, while poor wound healing can cause scarring and tissue contraction.

Ingenskin Therapeutics is developing skin grafts from patients' own cells for burns and chronic wounds. It combines keratinocytes, fibroblasts and pigment-producing melanocytes in one living construct, aiming to restore skin structure, function and natural colour.